Atlas Trials

A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

Clinical trial NCT05678010 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05678010
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Solid TumorMetastatic Solid TumorSolid CarcinomaSolid Tumor, AdultMetastatic TumorMetastatic Cancer
Start date
2023-05-17
Primary completion
2028-05-17
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.